Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$978.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| — |
| — |
| Open the original filing on SEC.gov |
| Feb 7 | ZVRA | Zevra Therapeutics, INC. | MEXER◷ | 37,500 | — | — | +10.3% | Open the original filing on SEC.gov |
| Feb 2 | ZVRA | Zevra Therapeutics, INC. | SSELL◷ | 91,000 | $9.38 | $853.4K | -20.0% | Open the original filing on SEC.gov |
| Jan 31 | ZVRA | Zevra Therapeutics, INC. | MEXER◷◆ | 233,334 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | ZVRA | Zevra Therapeutics, INC. | MEXER◷ | 233,334 | — | — | +105.1% | Open the original filing on SEC.gov |
| Jan 29 | ZVRA | Zevra Therapeutics, INC. | AGRANT◷◆ | 250,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 29 | ZVRA | Zevra Therapeutics, INC. | AGRANT◷◆ | 125,000 | — | — | — | Open the original filing on SEC.gov |